ArticleProceedings of the National Academy of Sciences of the United States of America2022

MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas.

Lauren E Stopfer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.